Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Inozyme Pharma Inc (INZY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Inozyme's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4.430 +0.010    +0.23%
14:57:09 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 423,616
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 4.380 - 4.550
Inozyme 4.430 +0.010 +0.23%

INZY Recent Sentiments

 
This page contains information on users’ sentiments for the Inozyme Pharma Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Apr 16, 2024 Przemysław Pachówka   4.860 Apr 22, 2024 @ 4.455 -8.33%
Apr 10, 2024 Jake Leaf   5.210 Apr 15, 2024 @ 4.880 -6.33%
Apr 09, 2024 Przemysław Pachówka   5.290 Apr 15, 2024 @ 4.880 -7.75%
Apr 06, 2024 Jeremy Benfield   6.410 Apr 08, 2024 @ 6.310 +1.56%
Mar 27, 2024 Wbeimar Meneses   6.900 Mar 28, 2024 @ 7.660 -11.01%
Mar 26, 2024 matanel liberman   7.180 Apr 19, 2024 @ 4.510 -37.19%
Mar 19, 2024 Jeremy Benfield   5.710 Mar 25, 2024 @ 5.970 +4.55%
Mar 14, 2024 Jeremy Benfield   6.000 Mar 18, 2024 @ 6.190 +3.17%
Mar 11, 2024 Greg Krawczyk   6.350 Mar 11, 2024 @ 6.010 -5.35%
Feb 29, 2024 Jeremy Benfield   6.190 Mar 04, 2024 @ 6.190 0.00%
Feb 12, 2024 Jeremy Benfield   5.940 Feb 19, 2024 @ 5.820 -2.02%
Jan 30, 2024 Jeremy Benfield   5.360 Feb 05, 2024 @ 5.280 -1.49%
Jan 25, 2024 Jeremy Benfield   4.490 Jan 29, 2024 @ 5.030 +12.03%
Nov 29, 2023 Gil Santos   3.800 Dec 04, 2023 @ 3.830 +0.79%
Oct 13, 2023 Ger Pinto   3.370 Nov 30, 2023 @ 3.690 -9.50%
Oct 11, 2023 Andrea Rilli   3.000 Nov 30, 2023 @ 3.690 +23.00%
Jun 13, 2023 Sefa Demir   6.030 Nov 30, 2023 @ 3.690 -38.81%
Apr 10, 2023 Vijaya Chandra Reddy   5.710 May 09, 2023 @ 5.980 +4.73%
Mar 02, 2023 Juan OP   2.790 Mar 24, 2023 @ 3.600 -29.03%
Feb 16, 2023 Vijaya Chandra Reddy   2.900 Mar 10, 2023 @ 2.770 -4.48%
Feb 16, 2023 Robbert Kuipers   3.030 Mar 10, 2023 @ 2.770 -8.58%
Feb 16, 2023 Robbert Kuipers   2.970 Feb 16, 2023 @ 3.040 +2.36%
Feb 16, 2023 Robbert Kuipers   3.000 Feb 16, 2023 @ 3.000 0.00%
Dec 09, 2022 Jose Lopez   1.540 Dec 12, 2022 @ 1.500 -2.60%
May 17, 2022 fatih sormagitsin   4.050 May 23, 2022 @ 4.300 +6.17%
Apr 22, 2022 Mario Agrifani   5.220 May 13, 2022 @ 4.230 -18.97%
Apr 21, 2022 Andreas Schatz   5.150 May 13, 2022 @ 4.230 -17.86%
Apr 21, 2022 Robbert Kuipers   5.170 May 13, 2022 @ 4.230 -18.18%
Apr 21, 2022 Robbert Kuipers   5.150 Apr 21, 2022 @ 5.150 0.00%
Apr 21, 2022 Paolo Costanzo   5.070 May 13, 2022 @ 4.230 -16.57%
Mar 17, 2022 Carsten Hess   4.260 Mar 21, 2022 @ 4.240 -0.47%
Dec 17, 2021 Robbert Kuipers   7.720 Jan 07, 2022 @ 6.490 -15.93%
Dec 17, 2021 Robbert Kuipers   7.720 Dec 17, 2021 @ 7.720 0.00%
Sep 14, 2021 StockExchange NYbroke   11.520 Sep 20, 2021 @ 11.490 +0.26%
Sep 08, 2021 Robbert Kuipers   14.250 Sep 13, 2021 @ 11.970 -16.00%
May 24, 2021 Robbert Kuipers   17.250 Jun 18, 2021 @ 15.430 -10.55%
Apr 23, 2021 Manuel Alejandro...   18.830 May 14, 2021 @ 15.840 -15.88%
Sep 08, 2020 Matt Wood   27.870 Oct 02, 2020 @ 21.000 -24.65%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

INZY Comments

Write your thoughts about Inozyme Pharma Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
matanel liberman
matanel liberman Mar 27, 2024 3:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
14$ soon
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email